The global cell line development market is experiencing strong growth, projected at a CAGR of approximately 8–10% over the forecast period. This growth is largely driven by the increasing adoption of ...
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...
Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.
New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...
Insourcing cell-line development has helped a fast-growing antibody manufacturer to deliver process improvements and strengthen communication with their contract manufacturer, according to Genmab, ...
Cell line creation is a major success factor in biologics manufacturing. It establishes the basis for product yield, quality, and long-term process stability. However, despite significant ...
Leadgene Biosolutions today announces the expansion of its product portfolio following its strategic integration into Leadgene Biomedical. The expanded portfolio supports both early-stage cell line ...
SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXia293 Stable ...
During a cell line development project, Agenus UK used the Amperia platform in combination with BLI and SPR to analyze antibody titers. The study found a good correlation between the platforms and ...
Cell line development continues to face technical and operational hurdles in transfection, clone selection, and media optimization. Manual screening, extended culture timelines, and fragmented data ...
Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto-Cellect® Fc Fusion, a novel assay designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback